MeSH term
Frequency | Condition_Probility | Animals | 24 | 0.0 |
Blotting, Western | 3 | 0.0 |
Female | 9 | 0.0 |
Male | 8 | 0.0 |
Pregnancy | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Time Factors | 6 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
Cell Line | 20 | 0.0 |
Humans | 56 | 0.0 |
Interferon Type I/*metabolism | 3 | 18.0 |
Ligands | 8 | 0.0 |
Mice | 10 | 0.0 |
Models, Molecular | 2 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Protein Binding/genetics | 2 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Transfection | 12 | 0.0 |
Binding Sites | 8 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Phosphorylation | 14 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Receptors, Interferon/*chemistry/metabolism | 2 | 100.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
src Homology Domains | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Interferon-alpha/metabolism | 3 | 13.0 |
Interferon-beta/metabolism | 2 | 10.0 |
Kinetics | 5 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 4 | 0.0 |
Proteins/*metabolism | 4 | 0.0 |
Receptors, Erythropoietin/metabolism | 3 | 9.0 |
Receptors, Interleukin/metabolism | 2 | 3.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Signal Transduction | 11 | 0.0 |
Tyrosine/metabolism | 4 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 6 | 0.0 |
Receptors, Interferon/*chemistry | 2 | 100.0 |
Comparative Study | 6 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Interferon-alpha/pharmacology | 6 | 6.0 |
*Protein-Tyrosine Kinase | 4 | 1.0 |
Interferons/metabolism | 2 | 8.0 |
Receptors, Interferon/*metabolism | 9 | 32.0 |
Base Sequence | 7 | 0.0 |
Cattle | 3 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Sheep | 2 | 0.0 |
Solubility | 2 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Adult | 6 | 0.0 |
Aged | 3 | 0.0 |
Middle Aged | 6 | 0.0 |
Treatment Outcome | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Interferon Type I/immunology/*metabolism | 2 | 100.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Interferon-alpha/*pharmacology | 2 | 1.0 |
Liver/*metabolism | 3 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Antiviral Agents/metabolism | 2 | 22.0 |
Cell Division | 3 | 0.0 |
Receptors, Interferon/chemistry/genetics/*metabolism | 3 | 37.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Structure-Activity Relationship | 5 | 0.0 |
Jurkat Cells | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Alkaline Phosphatase/metabolism | 2 | 1.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Dimerization | 3 | 0.0 |
Fibrosarcoma/metabolism | 2 | 16.0 |
*Gene Expression Regulation | 2 | 0.0 |
Interferon-alpha/*metabolism | 6 | 26.0 |
Interferon-beta/*metabolism | 3 | 25.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Receptors, Interferon/genetics/*metabolism | 5 | 83.0 |
Temperature | 3 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Chromosomes, Human, Pair 21/*genetics | 2 | 2.0 |
Genes, Reporter/genetics | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Clone Cells | 2 | 0.0 |
Receptors, Interferon/*genetics | 4 | 26.0 |
Sequence Alignment | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Mutation | 5 | 0.0 |
Sequence Deletion | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Trans-Activators/*metabolism | 3 | 0.0 |
Genotype | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Antiviral Agents/*pharmacology | 2 | 1.0 |
Conserved Sequence | 2 | 0.0 |
DNA, Complementary/chemistry | 2 | 1.0 |
Exons | 2 | 0.0 |
Receptors, Interferon/*genetics/metabolism | 2 | 28.0 |
Gene Expression | 3 | 0.0 |
Interferon Alfa-2b/*therapeutic use | 2 | 5.0 |
RNA, Viral/blood | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Interferon-beta/pharmacology | 2 | 4.0 |
Proteins/metabolism | 3 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Protein Conformation | 2 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 2 | 2.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
